Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma
Conclusions
RT/TMZ was safely delivered and might provide sustained control of extraneural metastases in PC. Although this retrospective report has limitations, RT/TMZ can be considered as a therapeutic option for the management of extraneural metastases in PC.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Cancer & Oncology | Carcinoma | Endocrinology | Hepatocellular Carcinoma | Liver | Liver Cancer | Neurology | Pituitary Tumor | Temodar | Toxicology | Urology & Nephrology